Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.03 by 133.33 percent. This is a 216.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $49.41 million which beat the analyst consensus estimate of $48.57 million by 1.72 percent. This is a 15.16 percent increase over sales of $42.90 million the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。